Departments of Neurology, Radiology, and Psychological Sciences, and is the William and Nancy Thompson Endowed Chair in Radiology, , University of Missouri-Columbia School of Medicine, Columbia, Missouri.
Fourth-year medical student at the School of Medicine, , University of Missouri-Columbia School of Medicine, Columbia, Missouri.
Mo Med. 2023 Jan-Feb;120(1):70-78.
As our population ages, there is interest in delaying or intervening in cognitive decline. While newer agents are under development, agents in mainstream use do not impact the course of diseases that cause cognitive decline. This increases interest in alternative strategies. Even as we welcome possible new disease-modifying agents, they are likely to remain costly. Herein, we review the evidence behind other complementary and alternative strategies for cognitive enhancement and prevention of cognitive decline.
随着人口老龄化,人们对延缓或干预认知能力下降产生了兴趣。虽然新的药物正在开发中,但主流药物并不能改变导致认知能力下降的疾病进程。这增加了对替代策略的兴趣。即使我们对可能的新的疾病修饰药物表示欢迎,但它们仍可能很昂贵。在此,我们回顾了其他补充和替代策略的证据,这些策略可用于认知增强和预防认知能力下降。